| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $25,792,870 ) (Continued on the next page) |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL155325 | Contribution of pulmonary ionocytes and neuroendocrine cells to ion transport-mediated airway surface liquid maintenance | 001 | 4 | NIH | 6/20/2024 | $36,357 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H3700066 | BLACK LUNG | 00 | 22 | HRSA | 5/30/2024 | $784,031 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI165922 | DNA induction of neutrophilic asthma | 000 | 4 | NIH | 7/30/2024 | $462,219 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 001 | 4 | NIH | 5/31/2024 | $53,935 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 000 | 4 | NIH | 2/20/2024 | $485,411 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI156901 | The Origin and Role of Pulmonary ILC2 Subsets in Anti-Helminth Immunity | 000 | 5 | NIH | 7/31/2024 | $553,233 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI157138 | ILC2 memory in asthma | 000 | 5 | NIH | 8/12/2024 | $606,388 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI152504 | Parkin in mitochondrial dysfunction and airway inflammation of obese asthma | 000 | 5 | NIH | 8/22/2024 | $712,997 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI150082 | Role of immunoproteasome in airway viral infection | 000 | 5 | NIH | 4/18/2024 | $555,914 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01DA057266 | Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy | 001 | 2 | NIH | 7/3/2024 | $538,289 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM137961 | Discovery of Novel Mechanisms of Action of Ubiquitin-Like Proteins in Cellular Stress Pathways | 001 | 5 | NIH | 8/13/2024 | $414,049 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM137961 | Discovery of Novel Mechanisms of Action of Ubiquitin-Like Proteins in Cellular Stress Pathways | 005 | 5 | NIH | 9/10/2024 | $383,023 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL144727 | Mechanisms of right ventricle adaptation to pulmonary hypertension | 000 | 5 | NIH | 9/12/2024 | $768,190 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL155894 | Interstitial macrophages in cigarette smoke-induced small airway remodeling | 000 | 3 | NIH | 12/27/2023 | $158,328 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL140039 | Lung Macrophage Programming in Acute Lung Injury | 002 | 7 | NIH | 6/19/2024 | $76,043 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL140039 | Lung Macrophage Programming in Acute Lung Injury | 001 | 7 | NIH | 1/29/2024 | $855,492 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 001 | 12 | NIH | 6/21/2024 | $58,121 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 000 | 12 | NIH | 2/27/2024 | $653,847 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL077328 | Ceramide-Induced Destruction in Emphysema | 000 | 19 | NIH | 6/6/2024 | $676,133 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI143837 | Maternal programming of the stem cell-basophil axis for asthma | 000 | 4 | NIH | 6/5/2024 | $610,821 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI151021 | Transcriptional Control of T Cell Function | 001 | 4 | NIH | 5/29/2024 | $41,000 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI151021 | Transcriptional Control of T Cell Function | 000 | 4 | NIH | 2/22/2024 | $369,000 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL141264 | Role of FABP5 in COPD Exacerbations | 002 | 5 | NIH | 7/29/2024 | $597,510 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL166938 | Interaction of fibroblasts with cell corpses increases collagen synthesis during lung repair | 000 | 2 | NIH | 6/26/2024 | $605,515 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K01DK134835 | Transcriptional control of T cell function during type 1 diabetes | 000 | 1 | NIH | 12/6/2023 | $116,126 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI152037 | ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER | 000 | 5 | NIH | 3/14/2024 | $329,638 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 00 | 1 | HRSA | 8/1/2024 | $215,581 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI173502 | SUNBEAM Birth Cohort: Deciphering the role of early life skin dysfunction in development of the allergic march | 001 | 1 | NIH | 9/13/2024 | $129,777 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI173502 | SUNBEAM Birth Cohort: Deciphering the role of early life skin dysfunction in development of the allergic march | 000 | 1 | NIH | 9/6/2024 | $1,167,998 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AR077511 | Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy | 000 | 5 | NIH | 3/1/2024 | $187,525 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AR077511 | Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy | 000 | 5 | NIH | 3/1/2024 | $421,206 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UM1AI151958 | ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | 002 | 5 | NIH | 5/24/2024 | $0 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UM1AI151958 | ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | 001 | 5 | NIH | 4/25/2024 | $4,354,533 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL161238 | Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | 002 | 3 | NIH | 6/20/2024 | $79,680 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL161238 | Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | 001 | 3 | NIH | 1/29/2024 | $896,399 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R56AI180204 | Transcriptional Regulation of the Il13 Gene in Mast Cells | 001 | 1 | NIH | 6/21/2024 | $25,197 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R56AI180204 | Transcriptional Regulation of the Il13 Gene in Mast Cells | 000 | 1 | NIH | 1/4/2024 | $226,775 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21ES036375 | The Role of Airway Epithelial Complement in Chronic Beryllium Disease | 000 | 1 | NIH | 9/18/2024 | $470,500 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R00HL161320 | RNA editing controls pulmonary endothelial pathophenotypes in pulmonary hypertension | 000 | 3 | NIH | 8/9/2024 | $249,000 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL122995 | Asthma susceptibility due to environmental programming of innate immunity in utero | 001 | 10 | NIH | 6/26/2024 | $48,295 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL122995 | Asthma susceptibility due to environmental programming of innate immunity in utero | 000 | 10 | NIH | 12/1/2023 | $543,336 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL171850 | Bcl-2 dependent fibroblast resistance to apoptosis occurs through persistent IL-6 signaling | 000 | 1 | NIH | 7/9/2024 | $156,816 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL168278 | Reparative functions of human airspace macrophage subsets | 000 | 1 | NIH | 7/12/2024 | $602,955 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173030 | Activation of matrix metalloproteinase-9 is essential to overcome failed fibrosis resolution | 001 | 1 | NIH | 6/18/2024 | $67,876 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173030 | Activation of matrix metalloproteinase-9 is essential to overcome failed fibrosis resolution | 000 | 1 | NIH | 3/4/2024 | $610,880 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL162955 | Molecular Characterization of Progressive Pulmonary Sarcoidosis | 000 | 2 | NIH | 8/20/2024 | $772,729 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21AI178618 | Single Cell Genomics to Resolve Control of Immune Cell Function During Type 1 Diabetes | 000 | 2 | NIH | 5/15/2024 | $243,594 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AG073317 | Loss of progenitor function accelerates lung aging | 001 | 2 | NIH | 6/28/2024 | $69,108 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AG073317 | Loss of progenitor function accelerates lung aging | 000 | 2 | NIH | 3/4/2024 | $621,982 |
|
